Key facts
- It has raised $28.3M; the latest was Early Stage VC ($14.3M) in Jan 2026.
- Notable investors include IDG Capital, Beijing State-owned Capital Operation and Management, Lotus Lake Ventures, Shenzhen Yifeng Investment Management Enterprise, South China Venture Capital — 10 tracked in total.
- Status: Privately Held (backing).
Investors
10- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Yuewei Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Yuewei Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yuewei Medical
Developer of cardiac surgery implant interventional medical devices designed to promote the development of the industry. The company offers transformation and development of innovative products for the whole process of medical devices and equipment solutions in cardiac surgery, its products include coronary artery bypass graft cardiac fixator, intraoperative ultrasonic flow detector, left ventricular assist device, coronary anastomosis auxiliary system, providing customers with advanced medical devices.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2021
- Website
- yuewei.net.cn/
- Ownership
- Privately Held (backing)
Yuewei Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yuewei Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yuewei Medical in its N-PORT filings yet. We sweep new filings monthly.